All 132 BBC (VIRTUS BIOTECH CLINICAL TRIALS ETF) Holdings
There are 132 BBC holdings. Top 10 companies weight: 10.66%.
Total Market Cap: $312B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (132 stocks) | +12.97% | 8.31 | 4.33 | 0.25 | +59.48% | +10.00% | 1.25 | ||||||||||
101 | LXEO | Lexeo Therapeutics Inc | 0.68% | $4.66 | $351M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +348.28% | $21 | 0.00% | 1.99 |
102 | TSHA | N/A | 0.68% | $5.67 | $1.78B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +129.28% | $13 | -21.91% | 1.42 |
103 | TECX | Tectonic Therapeutic Inc | 0.68% | $32.80 | $612M | Biotechnology | Healthcare | -34.69% | N/A | N/A | N/A | N/A | N/A | 77 | +139.15% | $78 | -18.84% | 1.61 |
104 | SMMT | Summit Therapeutics Inc Ordinary Shares | 0.68% | $14.63 | $12B | Biotechnology | Healthcare | N/A | N/A | 3.72 | N/A | N/A | N/A | 60 | +96.24% | $29 | +13.03% | 1.76 |
105 | BEAM | Beam Therapeutics Inc | 0.67% | $27.29 | $3.17B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +91.68% | $52 | -22.11% | 1.82 |
106 | MLTX | Moonlake Immunotherapeutics Class A | 0.67% | $20.06 | $1.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +39.58% | $28 | +14.94% | 0.95 |
107 | EYPT | Eyepoint Inc | 0.67% | $13.05 | $1.16B | Biotechnology | Healthcare | +6.42% | N/A | 6.16 | N/A | N/A | N/A | 81 | +210.34% | $41 | +9.74% | 1.25 |
108 | ABUS | Arbutus Biopharma Corp | 0.67% | $4.52 | $898M | Biotechnology | Healthcare | N/A | 5.60 | 10.25 | N/A | N/A | N/A | 75 | +14.60% | $5.18 | +9.97% | 0.89 |
109 | IVVD | Invivyd Inc Ordinary Shares | 0.67% | $0.68 | $231M | Biotechnology | Healthcare | N/A | N/A | 44.64 | N/A | N/A | N/A | 75 | +1366.92% | $10 | 0.00% | 1.32 |
110 | RAPP | Rapport Therapeutics Inc | 0.66% | $42.56 | $1.91B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +33.08% | $57 | 0.00% | 1.27 |
111 | CMPX | Compass Therapeutics Inc Ordinary Shares | 0.66% | $2.10 | $385M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +304.76% | $8.50 | -15.76% | 1.55 |
112 | BCYC | Bicycle Therapeutics Plc Adr | 0.66% | $4.16 | $294M | Biotechnology | Healthcare | +11.06% | N/A | N/A | N/A | N/A | N/A | 72 | +203.37% | $13 | -34.65% | 1.26 |
113 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.66% | $3.08 | $1.76B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +135.39% | $7.25 | -38.84% | 2.63 |
114 | NAMS | Newamsterdam Pharma Co Nv | 0.66% | $32.34 | $3.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +53.71% | $50 | 0.00% | 1.02 |
115 | ANL | Adlai Nortye Ltd Adr | 0.65% | $13 | $317M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +120.00% | $29 | 0.00% | 1.08 |
116 | CELC | Celcuity Inc | 0.65% | $91.69 | $4.42B | Biotechnology | Healthcare | +36.83% | N/A | N/A | N/A | N/A | N/A | 79 | +78.26% | $163 | +33.98% | 1.07 |
117 | IMTX | Immatics Nv Ordinary Shares | 0.64% | $9.41 | $1.28B | Biotechnology | Healthcare | -15.05% | N/A | N/A | N/A | N/A | N/A | 75 | +100.74% | $19 | -5.61% | 1.29 |
118 | PRTA | Prothena Corp Plc | 0.64% | $8.75 | $447M | Biotechnology | Healthcare | -1.54% | N/A | 10.63 | N/A | N/A | N/A | N/A | +144.57% | $21 | -29.80% | 0.89 |
119 | STOK | Stoke Therapeutics Inc | 0.63% | $28.81 | $1.86B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +59.04% | $46 | -1.54% | 1.05 |
120 | WVE | Wave Life Sciences Ltd | 0.63% | $5.79 | $1.14B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +278.93% | $22 | -2.17% | 1.46 |
121 | ALLO | Allogene Therapeutics Inc | 0.63% | $1.85 | $465M | Biotechnology | Healthcare | -14.18% | N/A | N/A | N/A | N/A | N/A | 76 | +386.49% | $9 | -39.19% | 1.53 |
122 | ANAB | Anaptysbio Inc | 0.63% | $53.76 | $1.62B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 81 | +62.00% | $87 | +25.59% | 0.81 |
123 | TNGX | Tango Therapeutics Inc | 0.62% | $29.02 | $4.36B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +52.76% | $44 | +21.99% | 1.40 |
124 | INBX | Inhibrx Biosciences Inc | 0.62% | $87.61 | $1.33B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +216.74% | $278 | 0.00% | 1.39 |
125 | PROK | Prokidney Corp Ordinary Shares Class A | 0.61% | $1.60 | $138M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 57 | +291.85% | $6.25 | 0.00% | 2.40 |
126 | SEPN | Septerna Inc | 0.60% | $33.68 | $1.53B | Biotechnology | Healthcare | N/A | N/A | 107.53 | N/A | N/A | N/A | 77 | +33.61% | $45 | 0.00% | 1.24 |
127 | RLMD | Relmada Therapeutics Inc | 0.59% | $5.30 | $651M | Biotechnology | Healthcare | -0.59% | N/A | N/A | N/A | N/A | N/A | 80 | +139.06% | $13 | -27.40% | 0.90 |
128 | CABA | Cabaletta Bio Inc Ordinary Shares | 0.58% | $2.82 | $463M | Biotechnology | Healthcare | +8.20% | N/A | N/A | N/A | N/A | N/A | 72 | +374.47% | $13 | -19.26% | 1.66 |
129 | CBIO | Crescent Biopharma Inc | 0.55% | $16.64 | $432M | Biotechnology | Healthcare | +34.96% | N/A | N/A | N/A | N/A | N/A | 75 | +86.30% | $31 | 0.00% | 0.78 |
130 | CAPR | Capricor Therapeutics Inc | 0.50% | $19.79 | $1.17B | Biotechnology | Healthcare | +22.65% | N/A | 78.74 | N/A | N/A | N/A | 80 | +170.84% | $54 | +32.81% | 1.45 |
131 | EVMN | Evommune Inc | 0.40% | $12.21 | $448M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +155.14% | $31 | 0.00% | 0.78 |
132 | n/a | Cash | 0.21% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BBC (VIRTUS BIOTECH CLINICAL TRIALS ETF) Sector Allocation
HEALTHCARE
90.20%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%